OTCQX:MRVFF - Post by User
Comment by
PDMitchellon Apr 18, 2012 9:40am
240 Views
Post# 19806634
RE: FDA requires more info before
RE: FDA requires more info before Strange. Pliaglis was approved by the U.S. Food and Drug Administration (FDA) in June 2006 and was voluntarily removed from the U.S. market in 2008, due to manufacturing issues at Galderma’s contract manufacturer.
Surely the supplemental New Drug Application for Pliaglis concerned the new plant rather than approval per se. What additional info might the FDA Want?
Sisyphus and Nuvo have much in common!